High frequency of Th17 T cells in B-cell chronic lymphocytic leukemia - Preliminary report

Acta Haematologica Polonica

Volumn 39, Issue 2, 2008, Pages 237-244

  Giannopoulos, Krzysztof ^a,b   Schmitt, Michael ^a   Własiuk, Paulina ^b   Bojarska Junak, Agnieszka ^b   Chocholska, Sylwia ^b   Tomczak, Waldemar ^b   Roliński, Jacek ^b   Dmoszyńska, Anna ^b  

^a UNIVERSITY OF ULM   (Germany)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

B cell chronic lymphocytic leukemia (B CLL); Th17 cells (Th17)

Indexed keywords

INTERLEUKIN 17; IONOMYCIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL CHRONIC LYMPHATIC LEUKEMIA; CD3+ CD4+ IL 17 T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; MALE; T LYMPHOCYTE; TH17 CELLS;

EID: 45149117950     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ravandi F, O'Brien S. Immune defects in patients with chronic lymphocytic leukemia. Cancer Immunol Immunofher. 2006; 55: 197-209.
2. Giannopoulos K, Schmitt M. Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia. Leuk Lymphoma. 2006; 47: 2028-36.
3. Ghia P, Scielzo C, Frenquelli M, Muzio M, Caligaris-Cappio F. From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity. Autoimmun Rev. 2007; 7: 127-31.
4. Mellstedt H, Choudhury A. T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil. Cancer Immunol Immunother. 2006; 55: 210-20.
5. Ritgen M, Stilgenbauer S, von Neuhoff N, Humpe A, Bruggemann M, Pott C, Raff T, Krober A, Bunjes D, Schlenk R, Schmitz N, Döhner H, Kneba M, Dreger P. Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR. Blood. 2004; 104: 2600-2.
6. Giannopoulos K, Schmitt M, Wlasiuk P, Chen J, Bojarska-Junak A, Kowal M, Rolinski J, Dmoszynska A. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide. Leukemia. 2008; 22: 222-4.
7. Amiot L, Le Friec G, Sebti Y, Drénou B, Pangault C, Guilloux V, Leleu X, Bernard M, Facon T, Fauchet R. HLA-G and lymphoproliferative disorders. Semin Cancer Biol. 2003;13: 379-85.
8. Fayad L, Keating MJ, Reuben JM, O'Brien S, Lee BN, Lerner S, Kurzrock R. Interleukin-6 and interleukin-10 levels in chronic lymphocytic leukemia: correlation with phenotypic characteristics and outcome. Blood. 2001; 97: 256-63.
9. Lotz M, Ranheim E, Kipps TJ. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med. 1994;179: 999-1004.
10. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med. 10: 801-5, 2004.
11. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006; 24: 209-26.
12. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008 (in press).
13. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fill L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, Romagnani S. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204: 1849-61.
14. Kryczek I, Wei S, Zou L, Altuwaijri S, Szeliga W, Kolls J, Chang A, Zou W. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J Immunol. 2007; 178: 6730-3.
15. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007; 8: 967-74.
16. Mangan PR., Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234.
17. Park H, Li Z, Yang X. O, Chang SH, Nurieva R, Wang Y.-H, Wang Y, Hood L, Zhu Z, Tian Q, Dong C: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immun. 2005; 6: 1133-1141.